Association of Diabetes Care & Education Specialists


AstraZeneca Educational Webinar Series

Presented by ADCES in association with AstraZeneca-US Medical Affairs, CVMD Division

This free educational webinar series is designed to provide the most up-to-date, cutting edge information in diabetes. Each webinar will be presented live and recorded. Archived presentations will be posted on this page for up to 90 days after the live broadcast, so don't miss out!

This webinar series is educational in nature and contains no promotional or product information. CE credit is not available.

Upcoming Webinars:

All webinars are held from 1:00-2:00 pm EST.

June 9, 2021

2021 Guideline Updates and Implications to Patient Care

Registration coming soon


September 8, 2021

Bridging the Gap: Disparities in Heart Failure Associated with T2D: An Opportunity to Improve Care in the African-American Community

Registration coming soon


November 10, 2021

Overview of Therapeutic Options in the Treatment of NASH/NAFLD

Registration coming soon


Webinar Recordings


Cardio-Renal Complications of Type 2 Diabetes: The Link Between Cardiovascular and Renal Disease

Originally presented on February 10, 2021 by Karthik Linganathan, MD, FHFSA, MBA and Curtis Triplitt, PharmD, CDCES, FADCES

There is an elevated risk that people with type 2 diabetes have for cardiovascular disease (CVD) and chronic kidney disease (CKD). In this webinar, we'll review recent CVOT trials in type 2 diabetes and how learnings from these informed trials for heart failure (HF) and diabetic kidney disease (DKD). We'll also look at recent trials that looked at using SGLT2 inhibitors as treatments for patients with HF and CKD, both with and without type 2 diabetes. There will also be an overview of updated guidelines.

Upon completion of this activity, participants will be able to:

  1. Describe the elevated risk that patients with type 2 diabetes have for CVD and CKD
  2. Discuss the continuum of disease progression for CVD and CKD

Impact of COVID-19 and New Treatment Approaches

Originally presented on April 7, 2021 by Rachelle Richner, MSN, CRNP, NP-C and Julia Blanchette, PhD, RN, CDCES

This timely webinar will give an overview of what we know about the COVID-19 disease state, including pathophysiology and signs and symptoms. We'll profile high risk patient groups and how to address risk mitigation within these groups. And finally, we look at COVID-19 vaccines: what vaccines are currently available and what's coming; vaccine development and currently approved treatments; efficacy, dosing, and storage options for each vaccine; and a review of data from recent studies.

Upon completion of this activity, participants will be able to:

  1. Understand the basics of COVID-19 in a rapidly changing environment
  2. Discuss the national and international impact of COVID-19
  3. Explore patient groups at high-risk for COVID-19
  4. Discuss risk mitigation strategies for individuals
  5. Discuss new treatment methods, vaccine development, and guideline-recommended therapy